Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 38,292 $ 18,919
Accounts receivable, net 3,130 2,177
Other receivables 2,056 2,208
Inventory, net 0 3
Prepaid expenses and other current assets 2,465 2,660
Restricted cash, current portion 153 38
Total current assets 46,096 26,005
Property and equipment, net 1,530 1,607
Intangible assets, net 1,161 1,585
Goodwill 14,409 14,409
Restricted cash, net of current portion 149 149
Total assets 63,345 43,755
Current liabilities:    
Accounts payable 11,913 2,574
Accrued expenses and other current liabilities 14,238 11,310
Current liabilities of discontinued operations 209 1,341
Total current liabilities 26,360 15,225
Royalty obligation 2,000 2,000
Deferred tax liability, net 111 90
Other long-term liabilities 1,719 1,878
Total liabilities 30,190 19,193
Stockholders’ equity:    
Common stock—$0.001 par value; 200,000,000 shares authorized at March 31, 2021 and December 31, 2020; 89,104,816 and 75,004,127 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively 89 75
Preferred stock—$0.001 par value; 5,000,000 shares authorized at March 31, 2021 and December 31, 2020; 1,257,143 shares issued and outstanding at March 31, 2021 and December 31, 2020 1 1
Additional paid-in capital 241,535 202,276
Accumulated deficit (208,470) (177,790)
Total stockholders’ equity 33,155 24,562
Total liabilities and stockholders’ equity $ 63,345 $ 43,755